Prevention of gastric ulcer recurrence with tetraprenylacetone

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 1, 1998, Pages 44-48

  Nagasawa, Y ^a,b   Tatsuta, M ^a   Iishi, H ^a   Ishiguro, S ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cytoprotective agent; Gastric ulcer; Microvascular architecture; Prevention of ulcer recurrence; Tetraprenylacetone

Indexed keywords

ALKALINE PHOSPHATASE; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; OMEPRAZOLE; TEPRENONE;

ADULT; AGED; ARTICLE; CELL PROTECTION; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT PEPTIC ULCER; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING;

ADULT; AGED; ANTI-ULCER AGENTS; DITERPENES; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; OMEPRAZOLE; RECURRENCE; STOMACH ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 0031936239     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850166194     Document Type: Article

References (24)

1. Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T. Antiulcer effect of geranylgeranylacetone, a new acyclic polisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforsch 1981;31:799-804.
2. Tanaka M, Hasegawa J, Tsutsumi J. Determination of the antiulcer agent geranylgeranylacetone in serum by gas chromatography-mass spectrometry. J Chromatogr 1982;231:301-10.
3. Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T. Effects on the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats. Jpn J Pharmacol 1982;32:299-306.
4. Murakami M, Oketani K, Fujisaki H, Wakabayashi T. Effects of geranylgeranylacetone (GGA) on gastric lesions induced by topical aspirin plus HCl. Jpn J Pharmacol 1982;32:921-4.
5. Arakawa T, Yamada H, Nakamura A, Nebiki H, Fukuda T, Nakamura H, et al. Gastric cytoprotection by tetraprenylacetone in human subjects. Digestion 1988;39:111-7.
6. Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel antiulcer drug, stimulates mucus synthesis and secretion in rat gastric culture cells. Digestion 1986;33:206-10.
7. Nagasawa Y, Ishikawa H, Iishi H, Tatsuta M, Ishiguro S. Evaluation of gastric ulcer healing with mucosal microvascular architecture. Hepatogastroenterology 1996;43:866-72.
8. Miyake T. Relationship between healing process of gastric ulcer and mucosal defensive factors of the stomach, with special reference of the close-up magnifying study of gastric mucosal surface. Jpn Arch Intern Med 1980;27:187-205.
9. Takeuchi I. Observation of capillary network in gastric mucosa with biopsy specimen - mucosal redness found by gastroendoscopical examination and the structure of capillaries. Gastroenterol Endosc 1986;28:957-66 (in Japanese).
10. Barlow TE. Arteriovenous anastomosis in the human stomach. J Anat 1951;85:1-5.
11. Freeman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Zhang Z-F, et al. The relationship between smoking exposure and p53 overexpression in colorectal cancer. Br J Cancer 1996;73:902-8.
12. Miller RG Jr. Simultaneous statistical influence. New York: McGraw Hill; 1966.
13. Siegel S Nonparametric statistics for the behavioral sciences. New York: McGraw Hill; 1956.
14. Snedector CW, Cochran WC. Statistical methods. Ames (IA): Iowa State University Press; 1967.
15. Saigenji K, Okabe H, Nomura K, Ueno H. Effect of Selbex in combination with cimetidine on healing and recurrence of gastric ulcers. Rinsho To Kenkyu 1988;65:1687-92 (in Japanese).
16. Miyake T, Ariyoshi J, Suzuki T, Oishi M, Sakai M, Ueda S. Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers. Dig Dis Sci 1980;25:1-7.
17. Shirakabe H, Takemoto T, Kobayashi K, Ogoshi K, Kimura K, Nakamura K, et al. Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: a nationwide, multicenter clinical study. Clin Ther 1995;17: 924-35.
18. Sakai M, Miyake A, Yamamoto H, Ito A, Kodera T, Tsuji K, et al. Endoscopic and electron microscopic evaluation of peptic ulcers treated with teprenone in combination with famotidine. Jpn Arch Intern Med 1993;40:185-94.
19. Tatsuta M, Yamamoto R, Iishi H, Nakaizumi A. Scanning electron microscopic observations on gastric mucus secretion in rats, and the effects of tetraprenylacetone. Digestion 1995;56: 175-80.
20. Guslandi M, Testoni PA, Fesce E, Ballarin E, Tittobello A. Behaviour of gastric mucin during pirenzepine treatment, a double-blind controlled study versus cimetidine. Curr Ther Res 1980;27:714-8.
21. Takiuchi H, Asada S, Umegaki E, Tabashi T, Yoshimura K, Matsumoto A, et al. Role of a cytoprotective agent in combination with proton pump inhibitor in ulcer treatment. Rynsho To Kenkyu 1993;70:3666-70 (in Japanese).
22. Nakamura M, Kitaiima M, Tsuchiya M. Alteration of gastric microcirculation in ulcer healing and recurrence: significance of autonomic nervous regeneration and mesenchymal cell. Gastroenterol Jpn 1993;28 Suppl 5:139-44.
23. Tabashi T, Asada S, Umegaki E, Takiuchi H, Katsu K. Effects of ammonia solution on growth factors and gastric mucus in acetic acid-induced gastric ulcers in rats. Gastroenterology 1996;110:A268.
24. Axon ATR, O'Morain CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RPH, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997;314: 565-8.